About: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1993 (uk) im März 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1993 (ast) scientific article published on 01 March 1993 (en)
publication date	wds:Q64127579-9A47E5B2-0B47-4BFF-BBAA-E4AC11644852
publication date	1993-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64127579-91215F1A-73EB-47A8-97AD-14218A20172F
language of work or name	English
author name string	wds:Q64127579-17A5E25A-BBB8-44EF-8C72-3110DB5F03F8 wds:Q64127579-3823CAA5-E2CE-48DF-8D7F-BF1A4AC2F13E wds:Q64127579-4423AFE7-D407-4FCE-9D1F-91C91331587E wds:Q64127579-4FCB2BA5-063F-483E-9F75-6CD0048D47B6 wds:Q64127579-5562DED7-DB05-46D9-BDF9-6828BBA0EDF3 wds:Q64127579-821BBCB5-A8CD-46D2-BF0D-1CBEB2989532 wds:Q64127579-83151F94-3D99-43AF-B86A-7E3074C7F3E2 wds:Q64127579-BC2F7F73-3062-4513-BA37-78A3777DD126 wds:Q64127579-E7E5A511-E7F3-47AA-B3F7-B0FC71646339
author name string	R M Schein S J Harris E A Panacek P Nightingale S M Opal J L Zimmerman J F Dhainaut C J Fisher S Stephens
rdfs:label	Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group (en) Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group (nl)
skos:prefLabel	Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group (en) Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group (nl)
name	Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group (en) Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group (nl)
author	wds:Q64127579-D5B71BCE-68A8-4955-A3E9-41DFD9C8E568
author	Jean-Louis Vincent
title	wds:Q64127579-A8EB065B-597F-4C2F-AAF3-D4461E99CF65
title	Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group (en)
page(s)	wds:Q64127579-93C87B2F-31DD-4558-8516-9215E1B91C80
page(s)	318-327
instance of	wds:Q64127579-92ABFFDE-7826-43BF-9DE9-3E6796B9F9A2
instance of	scholarly article
main subject	wds:Q64127579-189D7D90-89CE-45C8-BF60-C507FABB0539 wds:Q64127579-6A521C2A-3271-4ECB-970B-8FE248D8A2F8
main subject	sepsis monoclonal antibody
PubMed ID	wds:Q64127579-80AA7B74-0A74-4B95-B70A-0C4E330BA0C5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8440099
PubMed ID	8440099
published in	wds:Q64127579-AAC6E93A-82B8-4729-8B64-708400C4B351
published in	Critical Care Medicine
issue	wds:Q64127579-655A66B9-5DB6-45D5-9E4F-EAA8BA6C8F6F
volume	wds:Q64127579-05072D36-827D-418E-8FE8-4276D04CA90B
issue	3
volume	21
DOI	wds:Q64127579-E23C9007-A4E1-49CB-86E9-02980FC26A17
DOI	http://dx.doi.org/10.1097/00003246-199303000-00006
DOI	10.1097/00003246-199303000-00006
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64127579
is cites work of	Taming TNF: strategies to restrain this proinflammatory cytokine Cytokine-processing enzymes. Stopping the cuts Severe sepsis and Toll-like receptors Advances in sepsis therapy The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock Febrile response induced by cecal ligation and puncture (CLP) in rats: involvement of prostaglandin E2 and cytokines Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trials: a meta-analysis Animal models of sepsis New strategies for combatting sepsis: the magic bullets missed the mark ... but the search continues Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. Changes in immune parameters and their correction in human cases of tick-borne encephalitis Deferoxamine reduces tissue injury and lethality in LPS-treated mice The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Immune dysfunction in trauma Stress Response to Hepatectomy in Patients with a Healthy or a Diseased Liver Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation Role of cytokines in sepsis. The evolution of modern trauma care Acute respiratory distress syndrome. Potential pharmacologic interventions Have we overestimated the benefit of human(ized) antibodies? Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis. Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis The Problems and Challenges of Immunotherapy in Sepsis* Translational systems approaches to the biology of inflammation and healing Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis Monocyte deactivation--rationale for a new therapeutic strategy in sepsis Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock Novel approaches to the prevention and therapy of neonatal bacterial sepsis. Monoclonal antibody therapy The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses Interleukin 10 reduces mortality from severe peritonitis in mice The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat Pathophysiology of sepsis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software